Literature DB >> 5318924

Drug effects and initial severity of symptomatology.

S Fisher, R S Lipman, E H Uhlenhuth, K Rickels, L C Park.   

Abstract

Mesh：

Substances：

Year:  1965        PMID： 5318924     DOI： 10.1007/BF00404165

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  2 in total

Review 1.  STATISTICAL TREATMENT OF THE LAW OF INITIAL VALUES (LIV) IN AUTONOMIC RESEARCH: A REVIEW AND RECOMMENDATION.

Authors:  L S BENJAMIN
Journal:  Psychosom Med       Date:  1963 Nov-Dec       Impact factor: 4.312

2.  Reduction of symptoms by pharmacologically inert substances and by short-term psychotherapy.

Authors:  L H GLIEDMAN; E H NASH; S D IMBER; A R STONE; J D FRANK
Journal:  AMA Arch Neurol Psychiatry       Date:  1958-03
  2 in total
  9 in total

1.  Informed consent and clinical trials: where is the placebo effect?

Authors:  C R Blease; F L Bishop; T J Kaptchuk
Journal:  BMJ       Date:  2017-02-03

2.  Group analysis versus individual response: the inferential limits of randomized controlled trials.

Authors:  John M Kelley; Ted J Kaptchuk
Journal:  Contemp Clin Trials       Date:  2010-07-16       Impact factor: 2.226

3.  Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy.

Authors:  E H Uhlenhuth; K Rickels; S Fisher; L C Park; R S Lipman; J Mock
Journal:  Psychopharmacologia       Date:  1966

4.  Screening for anticholinergic effects of atropine and chlordiazepoxide.

Authors:  L F Droppleman; D M McNair
Journal:  Psychopharmacologia       Date:  1968

Review 5.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

6.  Challenges in the development of clinical trials for major depressive disorder: lessons learned from trials in minor depression.

Authors:  Mark H Rapaport; Rachel E Maddux
Journal:  Dialogues Clin Neurosci       Date:  2002-12       Impact factor: 5.986

7.  Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus.

Authors:  Andrea W M Evers; Luana Colloca; Charlotte Blease; Marco Annoni; Lauren Y Atlas; Fabrizio Benedetti; Ulrike Bingel; Christian Büchel; Claudia Carvalho; Ben Colagiuri; Alia J Crum; Paul Enck; Jens Gaab; Andrew L Geers; Jeremy Howick; Karin B Jensen; Irving Kirsch; Karin Meissner; Vitaly Napadow; Kaya J Peerdeman; Amir Raz; Winfried Rief; Lene Vase; Tor D Wager; Bruce E Wampold; Katja Weimer; Katja Wiech; Ted J Kaptchuk; Regine Klinger; John M Kelley
Journal:  Psychother Psychosom       Date:  2018-06-12       Impact factor: 17.659

Review 8.  Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration.

Authors:  Tania B Huedo-Medina; Irving Kirsch; Jo Middlemass; Markos Klonizakis; A Niroshan Siriwardena
Journal:  BMJ       Date:  2012-12-17

9.  European Headache Federation recommendations for placebo and nocebo terminology.

Authors:  Dimos D Mitsikostas; Charlotte Blease; Elisa Carlino; Luana Colloca; Andrew L Geers; Jeremy Howick; Andrea W M Evers; Magne A Flaten; John M Kelley; Irving Kirsch; Regine Klinger; Antoinette MaassenVanDenBrink; Daniel E Moerman; Petros P Sfikakis; Lene Vase; Tor D Wager; Fabrizio Benedetti
Journal:  J Headache Pain       Date:  2020-09-25       Impact factor: 7.277
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.